BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35667901)

  • 1. Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database.
    Nasioudis D; Mastroyannis SA; Ko EM; Haggerty AF; Cory L; Giuntoli RL; Kim SH; Morgan MA; Latif NA
    Gynecol Oncol; 2022 Aug; 166(2):263-268. PubMed ID: 35667901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery.
    Nasioudis D; Wang X; Dhillon G; Latif N; Ko EM; Giuntoli RL; Gershenson D; Fader A; Carey M; Simpkins F
    Int J Gynecol Cancer; 2023 Dec; 33(12):1906-1912. PubMed ID: 37879909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic outcomes of uterine preservation for pre-menopausal patients with stage II epithelial ovarian carcinoma.
    Nasioudis D; Mulugeta-Gordon L; McMinn E; Byrne M; Ko EM; Cory L; Haggerty AF; Latif NA
    Int J Gynecol Cancer; 2021 Mar; 31(3):480-483. PubMed ID: 33649017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Factors of Early Stage Epithelial Ovarian Carcinoma.
    Hsieh SF; Lau HY; Wu HH; Hsu HC; Twu NF; Cheng WF
    Int J Environ Res Public Health; 2019 Feb; 16(4):. PubMed ID: 30795566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.
    Oseledchyk A; Leitao MM; Konner J; O'Cearbhaill RE; Zamarin D; Sonoda Y; Gardner GJ; Long Roche K; Aghajanian CA; Grisham RN; Brown CL; Snyder A; Chi DS; Soslow RA; Abu-Rustum NR; Zivanovic O
    Ann Oncol; 2017 Dec; 28(12):2985-2993. PubMed ID: 28950307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinoma.
    Nasioudis D; Latif NA; Ko EM; Cory L; Kim SH; Simpkins F; Morgan MA; Giuntoli RL
    Gynecol Oncol; 2023 Feb; 169():41-46. PubMed ID: 36502768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes.
    Nasioudis D; Mastroyannis SA; Albright BB; Haggerty AF; Ko EM; Latif NA
    Gynecol Oncol; 2018 Jul; 150(1):14-18. PubMed ID: 29751993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data Base.
    Nasioudis D; Latif NA; Simpkins F; Cory L; Giuntoli RL; Haggerty AF; Morgan MA; Ko EM
    Gynecol Oncol; 2020 Feb; 156(2):315-319. PubMed ID: 31839340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant Chemotherapy May Not Be Necessary for Women with Stage IC1 Epithelial Ovarian Cancer.
    Deng DM; Liao QY; Yang J; Chen J; Chen G; Bai HL; Zhang B; Li KZ
    Curr Med Sci; 2022 Feb; 42(1):192-200. PubMed ID: 34755262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of adjuvant chemotherapy on survival in patients with FIGO stage I high-grade serous ovarian cancer.
    van Baal JOAM; Van de Vijver KK; Algera MD; van der Aa MA; Sonke GS; van Driel WJ; Kenter GG; Amant FC; Lok CAR
    Gynecol Oncol; 2019 Jun; 153(3):562-567. PubMed ID: 30948193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is adjuvant chemotherapy necessary for young women with early-stage epithelial ovarian cancer who have undergone fertility-sparing surgery?: a multicenter retrospective analysis.
    Ikeda Y; Yoshihara M; Yoshikawa N; Yokoi A; Tamauchi S; Nishino K; Niimi K; Kajiyama H
    BMC Womens Health; 2022 Mar; 22(1):80. PubMed ID: 35313889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of incomplete surgery and adjuvant chemotherapy for the intraoperative rupture of capsulated stage I epithelial ovarian cancer: a multi-institutional study with an in-depth subgroup analysis.
    Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Mogi K; Kajiyama H
    J Gynecol Oncol; 2021 Sep; 32(5):e66. PubMed ID: 34378361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma.
    Nasioudis D; Haggerty AF; Giuntoli RL; Burger RA; Morgan MA; Ko EM; Latif NA
    Gynecol Oncol; 2019 Aug; 154(2):302-307. PubMed ID: 31155308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.
    García-Sáenz JA; Custodio A; Casado A; Vidart JA; Coronado PJ; Martín M; López-Tarruella S; Puente J; Fernández C; Díaz-Rubio E
    Clin Transl Oncol; 2011 Feb; 13(2):121-32. PubMed ID: 21324801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
    Song N; Gao Y
    Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival impact of low anterior resection in patients with epithelial ovarian cancer grossly confined to the pelvic cavity: a Korean multicenter study.
    Kim M; Suh DH; Park JY; Paik ES; Lee S; Eoh KJ; Nam JH; Lee YY; Kim JW; Kim S
    J Gynecol Oncol; 2018 Jul; 29(4):e60. PubMed ID: 29770630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is standard radical surgery necessary for elderly patients with early-stage epithelial ovarian carcinoma? ~Propensity score matched analysis~.
    Kajiyama H; Yoshihara M; Tamauchi S; Yoshikawa N; Niimi K; Suzuki S; Shibata K; Kikkawa F
    Jpn J Clin Oncol; 2020 Apr; 50(4):411-418. PubMed ID: 31837651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer.
    Joseph N; Clark RM; Dizon DS; Lee MS; Goodman A; Boruta D; Schorge JO; Del Carmen MG; Growdon WB
    Gynecol Oncol; 2015 Jun; 137(3):401-5. PubMed ID: 25839911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary.
    Nasioudis D; Mastroyannis SA; Haggerty AF; Giuntoli RL; Morgan MA; Ko EM; Latif NA
    Eur J Obstet Gynecol Reprod Biol; 2020 May; 248():63-70. PubMed ID: 32182501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Practice of Adjuvant Chemotherapy in Patients with Early-Stage Epithelial Ovarian Cancer.
    Frielink LM; Pijlman BM; Ezendam NP; Pijnenborg JM
    Chemotherapy; 2016; 61(6):287-94. PubMed ID: 27074010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.